Supreme Court Voids Human Gene Patents

Fallout from unanimous U.S. Supreme Court ruling could be limited.

, The National Law Journal

   |1 Comments

Reversing decades of federal patent awards, the U.S. Supreme Court on Thursday unanimously ruled that human genes and the information they encode are not patent-eligible.

This article has been archived, and is no longer available on this website.

View this content exclusively through LexisNexis® Here

Not a LexisNexis® Subscriber?

Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

  • tom

    seems like a serious impediment for continued research in genetics. The fact that it took a private company this much time and money to ID the gene could indicate that in the future, private labs and companies will not be able to raise funds for such research. I know I wouldn't invest in a company whose intellectual property could be taken without compensation. And look at what happened to that stock price upon this decision - down 25%.

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202604149791

Thank you!

This article's comments will be reviewed.